News German sites added to Europe's cardiometabolic R&D network The BioInnovation Institute (BII) has expanded a European network to develop drugs for cardiometabolic diseases and launch new biotechs into Germany.
News Novo Nordisk Foundation pledges €736m for European biotech Novo Nordisk Foundation is pumping funding into a Copenhagen-based biotech incubator, seeking to address the challenge of funding access in Europe.
News Novo Nordisk's chairman quits amid Foundation row Novo Nordisk's chairman Helge Lund will step down next month under pressure from the group's controlling shareholder, the Novo Nordisk Foundation.
News Novo Nordisk Foundation gives $75m for R&D 'challenges' The Novo Nordisk Foundation's latest round of R&D funding will go towards projects in biomanufacturing, cardiometabolic diseases, and AI.
News Novo Nordisk's dropping share price spells the end for CEO Novo Nordisk's chief executive Lars Fruergaard Jørgensen is stepping down by "mutual agreement" with the company's board.
R&D Partner Content Novo Nordisk seeks to target heart disease with Cardior acqu... Cardior CSO will speak at the Oligonucleotide Therapeutics and Delivery conference following announcement of a buyout by Novo Nordisk to enhance their
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.